JORGE E CORTES to Infusions, Subcutaneous
This is a "connection" page, showing publications JORGE E CORTES has written about Infusions, Subcutaneous.
Connection Strength
0.112
-
Subcutaneous omacetaxine mepesuccinate in patients with chronic-phase chronic myeloid leukemia previously treated with 2 or more tyrosine kinase inhibitors including imatinib. Clin Lymphoma Myeloma Leuk. 2013 Oct; 13(5):584-91.
Score: 0.112